CN106659704B - 治疗孤独症谱系障碍的药物和用途 - Google Patents

治疗孤独症谱系障碍的药物和用途 Download PDF

Info

Publication number
CN106659704B
CN106659704B CN201580041707.XA CN201580041707A CN106659704B CN 106659704 B CN106659704 B CN 106659704B CN 201580041707 A CN201580041707 A CN 201580041707A CN 106659704 B CN106659704 B CN 106659704B
Authority
CN
China
Prior art keywords
hda
disorder
asd
pharmaceutically acceptable
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201580041707.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN106659704A (zh
Inventor
史蒂夫·张
文华芹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Florian Institute Of Neuroscience And Mental Health
Deakin University
Original Assignee
Florian Institute Of Neuroscience And Mental Health
Deakin University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2014902173A external-priority patent/AU2014902173A0/en
Application filed by Florian Institute Of Neuroscience And Mental Health, Deakin University filed Critical Florian Institute Of Neuroscience And Mental Health
Publication of CN106659704A publication Critical patent/CN106659704A/zh
Application granted granted Critical
Publication of CN106659704B publication Critical patent/CN106659704B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Insects & Arthropods (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN201580041707.XA 2014-06-06 2015-06-05 治疗孤独症谱系障碍的药物和用途 Active CN106659704B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2014902173A AU2014902173A0 (en) 2014-06-06 Methods of treating neurodevelopmental diseases and disorders
AU2014902173 2014-06-06
PCT/AU2015/050310 WO2015184509A1 (en) 2014-06-06 2015-06-05 Methods of treating neurodevelopmental diseases and disorders

Publications (2)

Publication Number Publication Date
CN106659704A CN106659704A (zh) 2017-05-10
CN106659704B true CN106659704B (zh) 2020-03-10

Family

ID=54765877

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580041707.XA Active CN106659704B (zh) 2014-06-06 2015-06-05 治疗孤独症谱系障碍的药物和用途

Country Status (12)

Country Link
US (3) US9925163B2 (enExample)
EP (1) EP3151824B1 (enExample)
JP (2) JP6598262B2 (enExample)
KR (1) KR102496390B1 (enExample)
CN (1) CN106659704B (enExample)
AU (3) AU2015271652B2 (enExample)
BR (1) BR112016028653A2 (enExample)
CA (1) CA2951288C (enExample)
ES (1) ES3014042T3 (enExample)
MX (1) MX377588B (enExample)
NZ (1) NZ727412A (enExample)
WO (1) WO2015184509A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106659704B (zh) 2014-06-06 2020-03-10 迪肯大学 治疗孤独症谱系障碍的药物和用途
WO2017093807A1 (en) * 2015-12-04 2017-06-08 The Florey Institute Of Neuroscience And Mental Health Methods of treating or alleviating mental disorders and associated symptoms
CN116570582A (zh) * 2023-05-19 2023-08-11 中国药科大学 10-羟基癸烯酸在制备重度抑郁治疗药物中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007130581A2 (en) * 2006-05-04 2007-11-15 Hardwicke Susan B Compositions and methods for psychiatric conditions and cognition enhancement
CN103816307A (zh) * 2014-03-12 2014-05-28 张国显 神经生长再造丸及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1025185A (en) 1911-03-23 1912-05-07 William J Gruss Regrinder.
JPH0967252A (ja) 1995-09-05 1997-03-11 Zenkoku Royal Jelly Kosei Torihiki Kiyougikai ローヤルゼリーに含まれるトランス−１０−ヒドロキシ−デセン酸を有効成分とするアンジオテンシン転換酵素阻害剤及びインスリン様作用剤
JP5447954B2 (ja) 2007-09-19 2014-03-19 公益財団法人名古屋産業科学研究所 神経栄養因子様作用剤
KR101627001B1 (ko) * 2008-06-17 2016-06-03 재팬 로얄 젤리 가부시키가이샤 인지 장해 개선제
SI2667715T1 (sl) * 2011-01-27 2017-11-30 Neuren Pharmaceuticals Limited Zdravljenje motenj avtističnega spektra z uporabo glicil-l-2-metilprolil-l-glutaminske kisline
US10052319B2 (en) 2012-04-26 2018-08-21 Sumitomo Dainippon Pharma Co., Ltd. Medicament for treating mental and behavioural disorders
US9428477B2 (en) 2012-04-27 2016-08-30 Nippon Zoki Pharmaceutical Co., Ltd. Trans-2-decenoic acid derivative and drug containing same
CN106659704B (zh) 2014-06-06 2020-03-10 迪肯大学 治疗孤独症谱系障碍的药物和用途
WO2017093807A1 (en) 2015-12-04 2017-06-08 The Florey Institute Of Neuroscience And Mental Health Methods of treating or alleviating mental disorders and associated symptoms

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007130581A2 (en) * 2006-05-04 2007-11-15 Hardwicke Susan B Compositions and methods for psychiatric conditions and cognition enhancement
CN103816307A (zh) * 2014-03-12 2014-05-28 张国显 神经生长再造丸及其制备方法

Also Published As

Publication number Publication date
AU2021221914A1 (en) 2021-09-23
JP2019214623A (ja) 2019-12-19
US10251856B2 (en) 2019-04-09
CA2951288A1 (en) 2015-12-10
WO2015184509A1 (en) 2015-12-10
EP3151824C0 (en) 2025-03-05
US10933043B2 (en) 2021-03-02
US20170087110A1 (en) 2017-03-30
EP3151824B1 (en) 2025-03-05
US20190314315A1 (en) 2019-10-17
CN106659704A (zh) 2017-05-10
CA2951288C (en) 2024-01-02
KR20170026457A (ko) 2017-03-08
US20180214405A1 (en) 2018-08-02
JP6598262B2 (ja) 2019-10-30
JP2017517574A (ja) 2017-06-29
EP3151824A1 (en) 2017-04-12
US9925163B2 (en) 2018-03-27
ES3014042T3 (en) 2025-04-16
JP6994613B2 (ja) 2022-01-14
MX2016016118A (es) 2017-07-26
BR112016028653A2 (pt) 2018-07-10
NZ727412A (en) 2023-07-28
AU2015271652A1 (en) 2017-01-05
KR102496390B1 (ko) 2023-02-03
EP3151824A4 (en) 2017-12-20
AU2015271652B2 (en) 2021-05-27
AU2025200041A1 (en) 2025-01-23
MX377588B (es) 2025-03-10

Similar Documents

Publication Publication Date Title
AU2025200041A1 (en) Methods of treating neurodevelopmental diseases and disorders
US11311539B2 (en) Compositions and methods for treatment of fragile X syndrome
JP2019511495A (ja) ＧＳＫ３β阻害薬チデグルシブによるＣＤＫＬ５障害の治療
US20220117925A1 (en) Methods of treating or alleviating mental disorders and associated symptoms
CN105517546A (zh) 治疗脆性x综合征及相关疾病的方法
KR20070084123A (ko) 양극성 장애 및 관련 증상의 치료
US20240398855A1 (en) Bromide source for use in treating autism spectral disorder
CN104473932B (zh) 治疗中枢神经系统炎症性脱髓鞘疾病的药物组合物及其联合给药的用途
HK1232805A1 (en) Methods of treating neurodevelopmental diseases and disorders
WO2024218483A1 (en) Sulindac and/or sulindac sulfide for the treatment of angelman syndrome
CN113423406A (zh) 用于治疗皮特-霍普金斯综合征的米诺环素
CN113453761A (zh) 皮特-霍普金斯综合征的治疗

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1232805

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1232805

Country of ref document: HK